The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
PEG conjugates in clinical development or use as anticancer agents: An overview
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Smith, T. J., Khatcheressian, J., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4451 · Cited by 1,636
Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
Lok, S., Kaushansky, K., Holly, R. D., Kuijper, J. L., Lofton-Day, C. E., Oort, P. J., Grant, F. J., Heipel, M. D., Burkhead, S. K., Kramer, J. M., et al. (1994) · Nature · doi:10.1038/369565a0 · Cited by 1,070
Peptide and protein PEGylation
Veronese, F. M. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00193-9 · Cited by 1,067
Self-citationKirkwood, J. M., Ibrahim, J. G., Sondak, V. K., Richards, J., Flaherty, L. E., Ernstoff, M. S., Smith, T. J., Rao, U., Steele, M., & Blum, R. H. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2444 · Cited by 912
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Thrombocytopenia caused by the development of antibodies to thrombopoietin
Li, J., Yang, C., Xia, Y., Bertino, A., Glaspy, J., Roberts, M., & Kuter, D. J. (2001) · Blood · doi:10.1182/blood.v98.12.3241 · Cited by 683
Eggermont, A. M., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Salès, F., Gore, M., MacKie, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61033-8 · Cited by 640
Polymer–drug conjugation, recent achievements and general strategies
Pasut, G., & Veronese, F. M. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.008 · Cited by 616
Self-citationFilgrastim (r-metHuG-CSF): the first 10 years
Welte, K., Gabrilove, J., Bronchud, M., Platzer, E., & Morstyn, G. (1996) · Blood · doi:10.1182/blood.v88.6.1907.bloodjournal8861907 · Cited by 599
Green, M. D., Koelbl, H., Baselga, J., Galid, A., Guillem, V., Gascon, P., Siena, S., Lalisang, R. I., Samonigg, H., Clemens, M. R., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg019 · Cited by 586
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Vogel, C. L., Wojtukiewicz, M. Z., Carroll, R. R., Tjulandin, S. A., Barajas-Figueroa, L. J., Wiens, B. L., Neumann, T. A., & Schwartzberg, L. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.102 · Cited by 482
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
Narta, U. K., Kanwar, S. S., & Azmi, W. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.009 · Cited by 384
Ganson, N. J., Kelly, S. J., Scarlett, E., Sundy, J. S., & Hershfield, M. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1861 · Cited by 350
EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS
Broome, J. D. (1963) · The Journal of Experimental Medicine · doi:10.1084/jem.118.1.99 · Cited by 348
Dinndorf, P. A., Gootenberg, J., Cohen, M. H., Keegan, P., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-991 · Cited by 324
Pegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315
Eggermont, A. M., Suciu, S., MacKie, R., Ruka, W., Testori, A., Kruit, W., Punt, C. J., Delauney, M., Sales, F., Groenewegen, G., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67482-x · Cited by 311
Mono-N-terminal poly(ethylene glycol)–protein conjugates
Kinstler, O., Molineux, G., Treuheit, M., Ladd, D., & Gegg, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00023-6 · Cited by 306
PEG-uricase in the management of treatment-resistant gout and hyperuricemia
Sherman, M. R., Saifer, M. G. P., & Perez-Ruiz, F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.011 · Cited by 291
Holmes, F. A., Jones, S. E., O’Shaughnessy, J., Vukelja, S., George, T., Savin, M., Richards, D., Glaspy, J., Meza, L., Cohen, G., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf130 · Cited by 291
The enzyme as drug: application of enzymes as pharmaceuticals
Vellard, M. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00092-2 · Cited by 283
Cheng, P. N.-M., Lam, T.-L., Lam, W.-M., Tsui, S.-M., Cheng, A. W.-M., Lo, W.-H., & Leung, Y.-C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 277
Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250
Abuchowski, A., Kazo, G. M., Cr, V., Es, T. V., Kafkewitz, D., Ml, N., At, V., & Ff, D. (1984) · PubMed · Cited by 249
Basser, R. L., O'Flaherty, E., Green, M., Edmonds, M., Nichol, J., Menchaca, D. M., Cohen, B., & Begley, C. G. (2002) · Blood · doi:10.1182/blood.v99.7.2599 · Cited by 249
Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
Rajender Reddy, K., Modi, M. W., & Pedder, S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00028-5 · Cited by 241
Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238
Introduction and overview of peptide and protein pegylation
(2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 235
Harker, L. A., Roskos, L. K., Marzec, U. M., Carter, R. A., Cherry, J. K., Sundell, B., Cheung, E. N., Terry, D., & Sheridan, W. (2000) · Blood · doi:10.1182/blood.v95.8.2514 · Cited by 228
Greenwald, R. B., Gilbert, C. W., Pendri, A., Conover, C. D., Xia, J., & Martinez, A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950475e · Cited by 223
Novel Prodrugs of SN38 Using Multiarm Poly(ethylene glycol) Linkers
Zhao, H., Rubio, B., Sapra, P., Wu, D., Reddy, P., Sai, P., Martinez, A., Gao, Y., Lozanguiez, Y., Longley, C., et al. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700333s · Cited by 188
Sapra, P., Zhao, H., Mehlig, M., Malaby, J., Kraft, P., Longley, C., Greenberger, L. M., & Horak, I. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4456 · Cited by 168
Bukowski, R. M., Tendler, C., Cutler, D., Rose, E., Laughlin, M. M., & Statkevich, P. (2002) · Cancer · doi:10.1002/cncr.10663 · Cited by 166
20-O-Acylcamptothecin Derivatives: Evidence for Lactone Stabilization
Zhao, H., Lee, C., Sai, P., Choe, Y. H., Boro, M., Pendri, A., Guan, S., & Greenwald, R. B. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo000221n · Cited by 162
Antitumoral activity of PEG–gemcitabine prodrugs targeted by folic acid
Pasut, G., Canal, F., Dalla Via, L., Arpicco, S., Veronese, F. M., & Schiavon, O. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.002 · Cited by 160
Self-citationHoltsberg, F. W., Ensor, M., Steiner, M. R., Bomalaski, J. S., & Clark, M. A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00042-1 · Cited by 155
Gong, H., Zölzer, F., Recklinghausen, G. V., Havers, W., & Schweigerer, L. (2000) · Leukemia · doi:10.1038/sj.leu.2401763 · Cited by 138
Rowinsky, E. K., Rizzo, J. D., Ochoa, L., Takimoto, C. H. M., Forouzesh, B., Schwartz, G. H., Hammond, L. A., Patnaik, A., Kwiatek, J., Goetz, A. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.143 · Cited by 132
In vivo anti‐tumor activity of arginine deiminase purified from Mycoplasma arginini
Takaku, H., Takase, M., Abe, S., Hayashi, H., & Miyazaki, K. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510213 · Cited by 123
Yang, Z., Wang, J., Lu, Q., Xu, J., Kobayashi, Y., Takakura, T., Takimoto, A., Yoshioka, T., Lian, C., Chen, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1822 · Cited by 123
Clinical pharmacology of polyethylene glycol-L-asparaginase.
Ho, D. H., Brown, N. S., Yen, A., Holmes, R., Keating, M. J., Abuchowski, A., Newman, R. A., & Krakoff, I. H. (1986) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08348-5 · Cited by 119
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
Is, P., Kang, S.-W., Shin, Y.-J., Chae, K.-Y., Park, M.-O., Kim, M. Y., Wheatley, D. N., & Min, B.-H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601181 · Cited by 97
PEG–Ara-C conjugates for controlled release
Schiavon, O., Pasut, G., Moro, S., Orsolini, P., Guiotto, A., & Veronese, F. M. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2003.10.005 · Cited by 95
Self-citationTreatment of Acute Lymphoblastic Leukaemia
Apostolidou, E., Swords, R. T., Alvarado, Y., & Giles, F. J. (2007) · Drugs · doi:10.2165/00003495-200767150-00004 · Cited by 91
Takaku, H., Matsumoto, M., Misawa, S., & Miyazaki, K. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03094.x · Cited by 89
PEG-epirubicin Conjugates with High Drug Loading
Pasut, G., Scaramuzza, S., Schiavon, O., Mendichi, R., & Veronese, F. M. (2005) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911505053377 · Cited by 87
Self-citationSawa, T., Wu, J., Akaike, T., & Maeda, H. (2000) · PubMed · Cited by 86
Sugimura, K., Ohno, T., Kusuyama, T., & Azuma, I. (1992) · Melanoma Research · doi:10.1097/00008390-199209000-00007 · Cited by 83
Armstrong, J. K. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8679-5_9 · Cited by 81
Scott, L. C., Yao, J. C., Benson, A. B., Thomas, A., Falk, S. J., Mena, R. R., Picus, J., Wright, J. R., Mulcahy, M. F., Ajani, J. A., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0746-2 · Cited by 78
Molecular and Cellular Regulators of Cancer Angiogenesis
Goh, P., Sze, D., & Roufogalis, B. D. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907783220462 · Cited by 73
Ton, N. C., Parker, G. J. M., Jackson, A., Mullamitha, S., Buonaccorsi, G. A., Roberts, C., Watson, Y., Davies, K. E., Cheung, S., Hope, L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1550 · Cited by 73
Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
Park, Y. K., Abuchowski, A., Davis, S., et al. (1981) · PubMed · Cited by 72
Recombinant arginine deiminase as a potential anti-angiogenic agent
Beloussow, K., Wang, L., Wu, J., Ann, D. K., & Shen, W. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00793-5 · Cited by 71
Misawa, S., Aoshima, M., Takaku, H., Matsumoto, M., & Hayashi, H. (1994) · Journal of Biotechnology · doi:10.1016/0168-1656(94)90050-7 · Cited by 69
Cheng, P., Leung, Y., Lo, W., Tsui, S. M., & Lam, K. C. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.050 · Cited by 64
Mueller, C., Al-Batran, S. E., Jaeger, E., Schmidt, B., Bausch, M., Unger, C., & Sethuraman, N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2533 · Cited by 49
CT-2103: A Novel Macromolecular Taxane with Potential Advantages Compared with Conventional Taxanes
Langer, C. J. (2004) · Clinical Lung Cancer · doi:10.3816/clc.2004.s.020 · Cited by 46
Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.
Abuchowski, A., Es, T. V., Palczuk, N. C., McCoy, J. R., & Davis, F. F. (1979) · PubMed · Cited by 43
Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis
Izzo, F., Montella, M., Orlando, A. P., Nasti, G., Beneduce, G., Castello, G., Cremona, F., Ensor, M., Holtzberg, F. W., Bomalaski, J. S., et al. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04463.x · Cited by 42
Arginine deiminase from Mycoplasma arthritidis. Properties of the enzyme from log phase cultures.
Weickmann, J. L., Himmel, M. E., Squire, P. G., & Fahrney, D. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34571-4 · Cited by 31
Wang, M., Basu, A., Palm, T., Hua, J., Youngster, S. K., Hwang, L. A., Liu, H.-C., Li, X., Peng, P., Zhang, Y., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060198y · Cited by 27
Guo, Z., Wheler, J. J., Naing, A., Mani, S., Goel, S., Mulcahy, M. F., Gamza, F., Longley, C. B., Buchbinder, A., & Kurzrock, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2556 · Cited by 13
Tanaka, H., Takama, H., Arai, Y., Azuma, J., Ohno, R., Ikeda, Y., & Mizoguchi, H. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00288.x · Cited by 4
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
Turecek, P. L., Bossard, M. J., Schoetens, F., & Ivens, I. A. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.015 · Cited by 733
Designing degradable hydrogels for orthogonal control of cell microenvironments
Kharkar, P. M., Kiick, K. L., & Kloxin, A. M. (2013) · Chem. Soc. Rev. · doi:10.1039/c3cs60040h · Cited by 717
Metadata
- Authors
- Pasut, G., & Veronese, F. M.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 61
- Issue
- 13
- Pages
- 1177-1188
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1992994818
- Cited by
- 457
- References
- 69
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.